Cat. No. | Product name | CAS No. |
DCC5276 |
Tyk2 Jh2-in-48
Novel highly potent and selective TYK2 JH2 inhibitor, providing robust inhibition in a mouse IL-12-induced IFNγ pharmacodynamic model as well as efficacy in an IL-23 and IL-12-dependent mouse colitis model |
|
DCC5277 |
Bll5 Maleate
First-in-class selective PRMT5 inhibitor, blocking EBV-driven B lymphocyte transformation and survival while leaving normal B cells unaffected |
880813-30-9 |
DCC5278 |
Tyr(po(nme2)2
Stable analog of phosphotyrosine (pTyr) |
|
DCC5279 |
Tyrosinase Inhibitor Thio-2
Novel competitive inhibitor of tyrosinase enzyme |
51146-75-9 |
DCC5280 |
U-101958 Maleate [224170-09-6]
Potent and selective dopamine D4 receptor antagonist |
224170-09-6 |
DCC5281 |
Ua62784
Novel potent inhibitor of microtubule polymerization, binding directly to tubulin α/β heterodimers via the colchicine-binding site, perturbing mitotic spindles, delaying cells in mitosis and promotes apoptosis |
313367-92-9 |
DCC5282 |
Uawj172
Novel potent and broad-spectrum antiviral agent against multiple strains of EV-D68, EV-A71, and CVB3, targeting the viral protein 2C |
878922-36-2 |
DCC5283 |
Ubp512
Selective modulator of NMDA_receptor>NMDA receptors, potentiates responses at GluN1/GluN2A |
1333112-78-9 |
DCC5284 |
Ubp618
Novel pan-inhibitor of GluN1/GluN2 receptors |
1333110-86-3 |
DCC5285 |
Ubp646
Novel pan potentiator of GluN1/GluN2 receptors |
1333213-35-6 |
DCC5286 |
Ubp684
Novel NMDAR positive allosteric modulator (PAM), robustly potentiating responses at all GluN1/GluN2 subtypes and at neuronal NMDARs |
1357838-47-1 |
DCC5287 |
Ubtr008295a
Novel Antagonist of the USP5 Zinc Finger Ubiquitin-Binding Domain (USP5 ZnF-UBD) |
6947-81-5 |
DCC5288 |
Ucb-11056
Modulator of cyclic AMP generation, amplifing induced cyclic AMP formation in rat brain tissue; Nootropic |
127390-77-6 |
DCC5289 |
ucb30889
Potent ligand of synaptic vesicle protein 2A (SV2A) |
650608-19-8 |
DCC5290 |
Ucb-6786
Novel inhibitor of TNF signalling by stabilising an asymmetric form of the trimer, displaying a concentration-dependent response curve and selectivity over the TNFR1 extracellular domain and control proteins |
537018-21-6 |
DCC5291 |
Ucb-6876
Novel inhibitor of TNF signalling by stabilising an asymmetric form of the trimer, displaying a concentration-dependent response curve and selectivity over the TNFR1 extracellular domain and control proteins |
637324-45-9 |
DCC5292 |
Ucb-fcrn-303
Novel allosteric modulator of neonatal Fc receptor (FcRn), binding to the extracellular domain of FcRn |
|
DCC5293 |
uc-ddc-918013
Selective competitive inhibitor of ATX-mediated hydrolysis of the lysophospholipase substrate FS-3 |
313685-55-1 |
DCC5294 |
uc-ddc-931126
Selective competitive inhibitor of ATX-mediated hydrolysis of the lysophospholipase substrate FS-3 |
736966-32-8 |
DCC5295 |
uc-ddc-966791
Competitive dual inhibitor of the hydrolysis FS-3 and the phosphodiesterase substrate p-nitrophenyl thymidine 5'-monophosphate |
485317-08-6 |
DCC5297 |
Uck2-in-135546734
Novel non-competitive UCK2 inhibitor, suppressing nucleoside salvage in cells both in the presence and absence of DHODH inhibitors |
|
DCC5298 |
Uck2-in-135546812
Novel non-competitive UCK2 inhibitor, suppressing nucleoside salvage in cells both in the presence and absence of DHODH inhibitors |